Science Explorer Back to mapMap
Discussion
Company · Tokyo · Japan

Mochida Pharmaceutical (Japan)

In research, Mochida Pharmaceutical (Japan) stands highest in Biochemistry, Genetics and Molecular Biology (#5,204 of 5,801 worldwide), Molecular Biology (#3,424 of 3,729 worldwide) and Medicine (#13,738 of 14,558 worldwide), over all time.

World rank, all time
#34,235
of 34,923
Rank in Japan
#1,831
of 1,923
Research works
948
▲ 42% vs 2018-21
Citations
20k
20.9 per fractional work
Top-10% rate
10.1%
all institutions 10.0%
vs its own fields
0.64×
1.00× is exactly expected
Open access
43%
world 40%
International
10%
world 18%

What is Mochida Pharmaceutical (Japan) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Biochemistry, Genetics and Molecular BiologyField #5,204 of 5,801 3.8%247
Molecular BiologySubfield #3,424 of 3,729 4.0%149
MedicineField #13,738 of 14,558 5.4%389
Life SciencesDomain #10,476 of 11,023 4.3%390
Health SciencesDomain #15,994 of 16,688 5.3%418
Physical SciencesDomain #17,351 of 17,446 5.8%129

Each strip is that field's whole ranked pool, with the notch where Mochida Pharmaceutical (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Mochida Pharmaceutical (Japan) work in?

In 2022-now, 53% of research at Mochida Pharmaceutical (Japan) is in Health Sciences, 37% in Life Sciences. Its largest fields are Medicine (47%), Biochemistry, Genetics and Molecular Biology (23%), Neuroscience (4%). It does 2.1× the world's share of Life Sciences.

Health Sciences: 18 fractional works · 52.5% of its workMedicine: 16 fractional works · 47.3% of its workPulmonary and Respiratory Medicine: 2 fractional works · 7.0% of its workSurgery: 2 fractional works · 5.1% of its workOncology: 1 fractional works · 3.6% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 3.3% of its workRheumatology: 1 fractional works · 2.9% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 2.8% of its workUrology: 1 fractional works · 2.8% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.0% of its workPharmacology: 1 fractional works · 1.9% of its workHematology: 1 fractional works · 1.7% of its workGastroenterology: 1 fractional works · 1.7% of its workEpidemiology: 0 fractional works · 1.5% of its workNephrology: 0 fractional works · 1.1% of its workPathology and Forensic Medicine: 0 fractional works · 1.1% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.0% of its workPhysiology: 0 fractional works · 0.9% of its workRehabilitation: 0 fractional works · 0.8% of its workReproductive Medicine: 0 fractional works · 0.8% of its workGenetics: 0 fractional works · 0.8% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.7% of its workComplementary and alternative medicine: 0 fractional works · 0.6% of its workBiochemistry: 0 fractional works · 0.5% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.5% of its workInfectious Diseases: 0 fractional works · 0.5% of its workObstetrics and Gynecology: 0 fractional works · 0.5% of its workImmunology and Allergy: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.2% of its workPsychiatry and Mental health: 0 fractional works · 0.2% of its workNursing: 1 fractional works · 3.2% of its workNutrition and Dietetics: 1 fractional works · 3.2% of its workHealth Professions: 0 fractional works · 1.2% of its workGeneral Health Professions: 0 fractional works · 0.6% of its workEmergency Medical Services: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.0% of its workDentistry: 0 fractional works · 0.8% of its workPeriodontics: 0 fractional works · 0.5% of its workOral Surgery: 0 fractional works · 0.2% of its workLife Sciences: 12 fractional works · 36.5% of its workBiochemistry, Genetics and Molecular Biology: 8 fractional works · 23.4% of its workMolecular Biology: 4 fractional works · 12.9% of its workGenetics: 1 fractional works · 3.5% of its workBiotechnology: 1 fractional works · 3.3% of its workCancer Research: 1 fractional works · 1.6% of its workCell Biology: 0 fractional works · 1.1% of its workEndocrinology: 0 fractional works · 0.6% of its workBiochemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 1 fractional works · 4.0% of its workSensory Systems: 1 fractional works · 2.1% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.8% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 3.9% of its workPharmaceutical Science: 1 fractional works · 2.1% of its workPharmacology: 1 fractional works · 1.7% of its workSmaller subfields together: 0 fractional works · 0.0% of its workImmunology and Microbiology: 1 fractional works · 3.3% of its workImmunology: 1 fractional works · 2.5% of its workMicrobiology: 0 fractional works · 0.9% of its workAgricultural and Biological Sciences: 1 fractional works · 2.0% of its workFood Science: 0 fractional works · 1.1% of its workGeneral Agricultural and Biological Sciences: 0 fractional works · 0.5% of its workPlant Science: 0 fractional works · 0.3% of its workPhysical Sciences: 3 fractional works · 9.1% of its workEngineering: 1 fractional works · 3.4% of its workBiomedical Engineering: 1 fractional works · 1.6% of its workMechanical Engineering: 0 fractional works · 0.8% of its workAerospace Engineering: 0 fractional works · 0.3% of its workAutomotive Engineering: 0 fractional works · 0.3% of its workOcean Engineering: 0 fractional works · 0.3% of its workChemistry: 1 fractional works · 2.4% of its workOrganic Chemistry: 0 fractional works · 0.9% of its workAnalytical Chemistry: 0 fractional works · 0.8% of its workInorganic Chemistry: 0 fractional works · 0.3% of its workSpectroscopy: 0 fractional works · 0.3% of its workComputer Science: 0 fractional works · 1.3% of its workComputer Vision and Pattern Recognition: 0 fractional works · 1.3% of its workMaterials Science: 0 fractional works · 1.0% of its workMaterials Chemistry: 0 fractional works · 1.0% of its workChemical Engineering: 0 fractional works · 0.3% of its workBioengineering: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.3% of its workGeology: 0 fractional works · 0.3% of its workEnvironmental Science: 0 fractional works · 0.3% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.3% of its workSocial Sciences: 1 fractional works · 1.9% of its workPsychology: 0 fractional works · 0.7% of its workClinical Psychology: 0 fractional works · 0.4% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.6% of its workGeneral Economics, Econometrics and Finance: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.5% of its workEducation: 0 fractional works · 0.5% of its workALL ITS WORKMochidaPharmaceutical…33fractional works, 2022-now
Life Sciences37%Physical Sciences9%Health Sciences53%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Medicine1647.3%
    2. Nursing13.2%
    3. Health Professions01.2%
    4. Dentistry00.8%
    1. Biochemistry, Genetics and Molecular Biology823.4%
    2. Neuroscience14.0%
    3. Pharmacology, Toxicology and Pharmaceutics13.9%
    4. Immunology and Microbiology13.3%
    5. Agricultural and Biological Sciences12.0%
    1. Engineering13.4%
    2. Chemistry12.4%
    3. Computer Science01.3%
    4. Materials Science01.0%
    5. Chemical Engineering00.3%
    6. Earth and Planetary Sciences00.3%
    7. Environmental Science00.3%
    1. Psychology00.7%
    2. Economics, Econometrics and Finance00.6%
    3. Social Sciences00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.41× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.38× its world share, 8 worksBiochemistry, Geneti…Immunology and Microbiology: 3.31× its world share, 1 worksImmunology and Micro…Neuroscience: 2.49× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 10.96× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 0.95× its world share, 0 worksChemical EngineeringChemistry: 1.51× its world share, 1 worksChemistryComputer Science: 0.17× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.21× its world share, 0 worksEarth and Planetary …Engineering: 0.23× its world share, 1 worksEngineeringEnvironmental Science: 0.07× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.28× its world share, 0 worksMaterials ScienceDentistry: 1.55× its world share, 0 worksDentistryHealth Professions: 0.45× its world share, 0 worksHealth ProfessionsMedicine: 2.46× its world share, 16 worksMedicineNursing: 6.59× its world share, 1 worksNursingEconomics, Econometrics and Finance: 0.29× its world share, 0 worksEconomics, Econometr…Psychology: 0.24× its world share, 0 worksPsychologySocial Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 11.0×. Every wedge is a field page.

All 19 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics10.96×1 works
  2. Nursing6.59×1 works
  3. Biochemistry, Genetics and Molecular Biology4.38×8 works
  4. Immunology and Microbiology3.31×1 works
  5. Neuroscience2.49×1 works
  6. Medicine2.46×16 works
  7. Dentistry1.55×0 works
  8. Chemistry1.51×1 works
  9. Chemical Engineering0.95×0 works
  10. Health Professions0.45×0 works
  11. Agricultural and Biological Sciences0.41×1 works
  12. Economics, Econometrics and Finance0.29×0 works
  13. Materials Science0.28×0 works
  14. Psychology0.24×0 works
  15. Engineering0.23×1 works
  16. Earth and Planetary Sciences0.21×0 works
  17. Computer Science0.17×0 works
  18. Environmental Science0.07×0 works
  19. Social Sciences0.04×0 works

Who are the top researchers at Mochida Pharmaceutical (Japan)?

Ranked on the quality score, Yoshinori Naoe, Masanori Nakakuki and Shizuka Mita lead among researchers whose main affiliation is Mochida Pharmaceutical (Japan).

  1. 1 Yoshinori Naoe Japan · #959,573 worldwide 4.1k citations · 67 works
  2. 2 Masanori Nakakuki Japan · #3,530,620 worldwide 2.3k citations · 36 works
  3. 3 Shizuka Mita Japan · #3,732,623 worldwide 1.3k citations · 15 works
  4. 4 MATSUHIKO ARATANI Japan · #4,645,016 worldwide 853 citations · 49 works
  5. 5 Toru Yamakawa Japan · #4,939,361 worldwide 417 citations · 17 works
  6. 6 Shoji Furusako Japan · #5,032,123 worldwide 985 citations · 27 works
  7. 7 Hachiro SENOH Japan · #5,082,798 worldwide 880 citations · 15 works
  8. 8 Youichi Miyamae Japan · #5,310,838 worldwide 5.5k citations · 17 works
  9. 9 Akiko Kawashima Japan · #5,466,788 worldwide 3.3k citations · 47 works
  10. 10 Shozo Sakuma Japan · #5,532,682 worldwide 1.6k citations · 35 works
All ranked researchers at Mochida Pharmaceutical (Japan)

What are the most cited papers from Mochida Pharmaceutical (Japan)?

The most cited paper from Mochida Pharmaceutical (Japan) is "Fas ligand in human serum" (Masato Tanaka, Takashi Suda, Kyosuke Haze et al., 1996), with 683 citations. Next come "In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction" (587) and "Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization" (359).

Most cited papers
#PaperReleasedCitations
1 Fas ligand in human serum Masato Tanaka, Takashi Suda, Kyosuke Haze et al. · Nature Medicine Mar 1996 683
2 In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction Ryuichi Morishita, Toshiko Sugimoto, Motokuni Aoki et al. · Nature Medicine Aug 1997 587
3 Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization Tomoyuki Igawa et al. · Nature Biotechnology 17 Oct 2010 359
4 Establishment of new preparation method for solid dispersion formulation of tacrolimus Kazunari Yamashita, Toshiomi Nakate, Kazuto Okimoto et al. · International Journal of Pharmaceutics 9 Oct 2003 348
5 Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis Kazuyoshi Kuwano, Naoki Hagimoto, Masayuki Kawasaki et al. · Journal of Clinical Investigation Open access Jul 1999 347
All 60 most cited papers, with filters and sorting

Which keywords describe research at Mochida Pharmaceutical (Japan)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Inflammation, Cancer, Epidemiology, Cardiovascular Disease, Biopharmaceuticals, Antioxidant, Pharmacology and Regeneration.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 14 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 14 words, with their numbers
  1. Inflammation4▲ 5.3×22 topics
  2. Epidemiology3▲ 2.3×17 topics
  3. Cancer3▲ 6.0×16 topics
  4. Cardiovascular Disease2▲ 5.0×10 topics
  5. Biopharmaceuticals1▲ 81×3 topics
  6. Oxidative Stress1▲ 2.6×8 topics
  7. Antioxidant1▲ 5.8×7 topics
  8. Metabolic Syndrome1▲ 4.7×7 topics
  9. Quality of Life1▲ 2.4×7 topics
  10. Ion Channels1▲ 29×3 topics
  11. Pharmacology1▲ 14×4 topics
  12. Recombinant Proteins1▲ 100×2 topics
  13. Regeneration1▲ 16×4 topics
  14. Tumor Microenvironment1▲ 6.7×4 topics

Which research topics does Mochida Pharmaceutical (Japan) publish most on?

By volume in 2022-now: Transgenic Plants and Applications, Ion Channels and Receptors, Fatty Acid Research and Health and Inflammatory Bowel Disease.

  1. 1 Transgenic Plants and Applications Biotechnology 1 works
  2. 2 Ion Channels and Receptors Sensory Systems 1 works
  3. 3 Fatty Acid Research and Health Nutrition and Dietetics 1 works
  4. 4 Inflammatory Bowel Disease Genetics 0 works
  5. 5 Pharmacological Effects of Natural Compounds Pharmacology 0 works
  6. 6 Pineapple and bromelain studies Molecular Biology 0 works
  7. 7 Hair Growth and Disorders Urology 0 works
  8. 8 Pelvic floor disorders treatments Rheumatology 0 works
  9. 9 Drug Solubulity and Delivery Systems Pharmaceutical Science 0 works
  10. 10 Receptor Mechanisms and Signaling Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available43.1%not open56.9%

World: 40% of research is openly available.

with international co-authors9.5%domestic only90.5%

World: 18% is written across borders.

How has Mochida Pharmaceutical (Japan)'s research output changed?

Output in 2022-2025 was 42% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Mochida Pharmaceutical (Japan) as a percentage of every work published that year, 0.00010% in 2024.

still counting0.0025%0.0050%0.0075%Mochida Pharmaceutical (Japan)0.00018% in 202519801990200020102020

Fractional works of Mochida Pharmaceutical (Japan) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

5%10%15%all institutions10.0% in 2005Mochida Pharmaceutical (Japan)7.6% in 20052000

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 8.9% in 1994.

Other research institutions in Tokyo

All research institutions in Tokyo

Share Mochida Pharmaceutical (Japan)'s ranking

Mochida Pharmaceutical (Japan) on Science Explorer

A card with Mochida Pharmaceutical (Japan)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Mochida Pharmaceutical (Japan). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.